THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Study backs dual therapy for brain cancer

Method parallels Kennedy regimen

By Stephen Smith
Globe Staff / March 9, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Nearly 10 percent of brain cancer patients who received radiation in combination with chemotherapy were still alive five years after diagnosis, the best long-term survival rate ever reported for a group of patients stricken with the aggressive tumor, researchers reported yesterday. (Full article: 608 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass

Boston.com top stories on Twitter

    waiting for twitterWaiting for Twitter to feed in the latest...